Dermapharm Holding SE

Dermapharm Holding SE

Verified
Offers dermatological, skin care, and allergy medicines.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$3.1b (Public information from Jul 2024)
Hünenberg Canton of Zug (HQ)

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2020202120222023202420252026
Revenues0000000000000000000000000000
% growth13 %19 %9 %11 %3 %5 %5 %
EBITDA0000000000000000000000000000
% EBITDA margin24 %37 %32 %23 %26 %27 %27 %
Profit0000000000000000000000000000
% profit margin11 %22 %13 %5 %10 %11 %11 %
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue2 %2 %1 %1 %---
  • Edit
DateInvestorsAmountRound
N/A

€328m

Valuation: €1.5b

3.2x EV/LTM Revenues

13.3x EV/LTM EBITDA

IPO
Total Funding000k

Recent News about Dermapharm Holding SE

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Dermapharm Holding SE

Edit
Arkopharma
ACQUISITION by Dermapharm Holding SE Jan 2023
Cannabinoid Compound Company
ACQUISITION by Dermapharm Holding SE Dec 2021